hotspot -WSS

hotspot

author：knowledge 2025-10-01 00:47:37 - browse：89768

Liver illustration — Hyacinth Empinado/STAT

SAN DIEGO — The American Diabetes Association said Sunday that all adults with type 2 diabetes or prediabetes should be screened for nonalcoholic fatty liver disease, an increasingly prevalent condition that can lead to serious liver damage.

There are no approved medications for the disease, but among available diabetes drugs, the ADA singled out GLP-1 treatments as an option doctors could consider, according to recommendations published during the annual ADA conference.

GLP-1 treatments, such as Ozempic and Mounjaro, are a class of drugs that have grown widely popular for their efficacy not only in lowering blood sugar, but also cutting weight. Drugmakers have started to study them in liver disease, and while some trials have shown they may offer some benefits, they haven’t yet been shown to improve harmful liver scarring.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： FDA seeks to regulate lab

focus

entertainment

Wikipedia

WSS

FDA's naming rule on biosimilars has undermined competition

Food as medicine: Medically tailored meals may get standardized

Covid vaccines: Private market messier than government rollout

Medicaid, Medicare dual

Eliminate the waiting period for sterilization covered by Medicaid

Covid vaccines: Private market messier than government rollout

explore

hotspot

focus

BioMarin wins approval for gene therapy to treat hemophilia A

How the Dana

After affirmative action ruling, medical educators look to 'holistic review'

Supreme Court mifepristone arguments center on docs' right to sue

How to save PrEP access — and even expand it

Listen: Who gets the credit for GLP

FDA approval of Sarepta Duchenne genetic therapy gives me hope

FDA seeks to regulate lab

Alkermes shareholders re

Oprah kicked off a national conversation on obesity. Let's have it

hotspot

Researchers use wearables data and AI to predict preterm birth risk

Roche subsidiary Foundation Medicine opens new headquarters

Cigna to pay $172 million to settle Medicare Advantage fraud probe

How the Dana

Data show record exodus of life scientists from academia

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

entertainment

knowledge

Wikipedia

focus